Linc02381 Exacerbates Rheumatoid Arthritis Through Adsorbing miR-590-5p and Activating the Mitogen-Activated Protein Kinase Signaling Pathway in Rheumatoid arthritis-fibroblast-like synoviocytes

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease. New evidence suggested that linc02381 suppressed colorectal cancer progression by regulating PI3 K signaling pathway, but the role of linc02381 in other diseases, such as RA, remains unclear. This study aimed to reveal the mechanism of linc02381 in RA progression. In vivo and in vitro, we found that linc02381 was upregulated in RA synovial tissues or RA fibroblast-like synoviocytes (RA-FLSs, P < 0.01), which were detected by quantitative real-time polymerase chain reaction. Cell Counting Kit-8, EDU, and Transwell assays revealed that linc02381 overexpression enhanced cell proliferation and invasion, and linc02381 knockdown inhibited cell proliferation and invasion in FLSs. Moreover, the results of bioinformatics analysis, luciferase reporter gene assay, and pull-down assay verified that linc02381 could directly bind with miR-590-5p. MiR-590-5p was downregulated in RA-FLSs, and overexpression of linc02381 suppressed expression of miR-590-5p that post-transcriptionally suppressed the expression of mitogen-activated protein kinase kinase 3 (MAP2K3), and overexpression of miR-590-5p reversed the effect of linc02381 overexpression on MAP2K3 expression. MiR-590-5p inhibitor reversed the inhibition effect of linc02381 knockdown on proliferation and invasion of FLSs, which enhanced expression of MAP2K3, and activation of p38 and AP-1 in the MAPK signaling pathway. In summary, linc02381 was upregulated in RA synovial tissues and RA-FLSs, and it exacerbated RA by adsorbing miR-590-5p to activate the MAPK signaling pathway.

[1]  M. Soleimani,et al.  Epigenetically silenced LINC02381 functions as a tumor suppressor by regulating PI3K-Akt signaling pathway. , 2020, Biochimie.

[2]  Zhuo Liu,et al.  The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway , 2019, Journal of Translational Medicine.

[3]  Weiling Xu,et al.  MicroRNA-124 alleviates the lung injury in mice with septic shock through inhibiting the activation of the MAPK signaling pathway by downregulating MAPK14. , 2019, International immunopharmacology.

[4]  Guoqing Li,et al.  LncRNA MEG3 inhibits rheumatoid arthritis through miR‐141 and inactivation of AKT/mTOR signalling pathway , 2019, Journal of cellular and molecular medicine.

[5]  Jianghua Liu,et al.  Upregulation of microRNA‑590 in rheumatoid arthritis promotes apoptosis of bone cells through transforming growth factor‑β1/phosphoinositide 3‑kinase/Akt signaling. , 2019, International journal of molecular medicine.

[6]  Xihai Zhang,et al.  LncRNA DILC participates in rheumatoid arthritis by inducing apoptosis of fibroblast-like synoviocytes and down-regulating IL-6 , 2019, Bioscience reports.

[7]  Yiran Huang,et al.  SPAG9/MKK3/p38 axis is a novel therapeutic target for liver cancer. , 2019, Oncology reports.

[8]  Zhao‐Jun Wei,et al.  Liquiritin from Glycyrrhiza uralensis Attenuating Rheumatoid Arthritis via Reducing Inflammation, Suppressing Angiogenesis, and Inhibiting MAPK Signaling Pathway. , 2019, Journal of agricultural and food chemistry.

[9]  Chi-Tang Ho,et al.  Resveratrol Alleviates Rheumatoid Arthritis via Reducing ROS and Inflammation, Inhibiting MAPK Signaling Pathways, and Suppressing Angiogenesis. , 2018, Journal of agricultural and food chemistry.

[10]  W. Liu,et al.  Dyrk1A promotes the proliferation, migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis via down-regulating Spry2 and activating the ERK MAPK pathway. , 2018, Tissue & cell.

[11]  U. Müller-Ladner,et al.  Rheumatoide Arthritis , 2018, Zeitschrift für Rheumatologie.

[12]  P. Roux‐Lombard,et al.  Value of Biomarkers in the Prevention of Rheumatoid Arthritis , 2017, Clinical pharmacology and therapeutics.

[13]  Xiaoling Li,et al.  MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer. , 2017, Cancer letters.

[14]  Xinliang Ma,et al.  Cardiac Fibroblast–Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling , 2017, Circulation.

[15]  Jun Xu,et al.  MAPK/P53-mediated FASN expression in bone tumors , 2017, Oncology letters.

[16]  Bin Wang,et al.  The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[17]  Yuan Yuan,et al.  miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway , 2016, OncoTargets and therapy.

[18]  Jia Song,et al.  MiR-21a-5p suppresses bisphenol A-induced pre-adipocyte differentiation by targeting map2k3 through MKK3/p38/MAPK. , 2016, Biochemical and biophysical research communications.

[19]  J. Batra,et al.  Systematic Identification, Characterization and Target Gene Analysis of microRNAs Involved in Osteoarthritis Subchondral Bone Pathogenesis , 2016, Calcified Tissue International.

[20]  Jing Luo,et al.  MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-κB. , 2016, International immunopharmacology.

[21]  Xiuhua Yang,et al.  miRNA expression profile of vulvar squamous cell carcinoma and identification of the oncogenic role of miR-590-5p. , 2016, Oncology reports.

[22]  G. Firestein,et al.  Decreased collagen-induced arthritis severity and adaptive immunity in MKK-6-deficient mice. , 2012, Arthritis and rheumatism.

[23]  Georg Schett,et al.  The pathogenesis of rheumatoid arthritis. , 2011, The New England journal of medicine.

[24]  U. Hellman,et al.  Proteome profiling of immortalization‐to‐senescence transition of human breast epithelial cells identified MAP2K3 as a senescence‐promoting protein which is downregulated in human breast cancer , 2010, Proteomics. Clinical applications.

[25]  E. Choi,et al.  Pathological roles of MAPK signaling pathways in human diseases. , 2010, Biochimica et biophysica acta.

[26]  R. Flavell,et al.  Role of MAPK Kinase 6 in Arthritis: Distinct Mechanism of Action in Inflammation and Cytokine Expression1 , 2009, The Journal of Immunology.

[27]  Jing-Yuan Fang,et al.  The MAPK signalling pathways and colorectal cancer. , 2005, The Lancet. Oncology.

[28]  G. Firestein,et al.  Expression and activation of mitogen-activated protein kinase kinases-3 and -6 in rheumatoid arthritis. , 2004, The American journal of pathology.

[29]  Jiahuai Han,et al.  p38 Mitogen-Activated Protein Kinase-Dependent Activation of Protein Phosphatases 1 and 2A Inhibits MEK1 and MEK2 Activity and Collagenase 1 (MMP-1) Gene Expression , 2001, Molecular and Cellular Biology.

[30]  C. Werning [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.